MarketBeat aggregated analyst ratings and Morgan Stanley reaffirmed an overweight rating for McKesson Corporation.
2 reports, 1 independent
Updated Aug 16
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat aggregated analyst ratings and Morgan Stanley reaffirmed an overweight rating for McKesson Corporation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
McKesson Corporation
U.S. healthcare supplies
-
MarketBeat
American personal finance blog
-
Morgan Stanley
U.S. investment bank
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- MarketBeat aggregated analyst ratings and price targets for LightPath Technologies, Inc. on May 27, 2026.
- MarketBeat aggregated analyst ratings for SM Energy, noting an upgrade from Truist Financial and a rating change from Raymond James Financial.
- MarketBeat reported research on Lionsgate shares, noting that Morgan Stanley issued an overweight rating, while Royal Bank of Canada increased its stake.
- Morgan Stanley downgraded enGene stock rating, which was reported by MarketBeat.